PHARMACYTE BIOTECH INC's ticker is and the CUSIP is 71715X953. A total of 3 filers reported holding PHARMACYTE BIOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $630 | -99.3% | 300 | -99.0% | 0.00% | – |
| Q2 2023 | $89,518 | -1.1% | 31,300 | +0.6% | 0.00% | – |
| Q1 2023 | $90,501 | +3.3% | 31,100 | +3.7% | 0.00% | – |
| Q4 2022 | $87,600 | -83.1% | 30,000 | -86.1% | 0.00% | -100.0% |
| Q3 2022 | $517,000 | +6.2% | 215,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $487,000 | – | 215,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 300 | $630 | 0.00% |
| SIMPLEX TRADING, LLC | 200 | $0 | 0.00% |